FemiClear is an over-the-counter brand that makes plant-based products for three common vaginal and genital conditions: yeast infections, bacterial vaginosis (BV), and genital herpes symptom relief. The products are marketed as natural alternatives to conventional drug-based treatments, using ingredients like oxygenated olive oil, tea tree oil, and thymol instead of standard antifungals or antivirals.
Yeast Infection Treatment
FemiClear’s yeast infection product is a vaginal ointment designed as a 2-day treatment. It uses calendula as a healing agent, tea tree oil (melaleuca) as an anti-yeast agent, and olive extract as an antimicrobial. The manufacturer claims the formula kills over 99% of yeast based on laboratory testing, though that testing was not conducted on humans or animals.
For context, standard yeast infection treatments like Monistat use miconazole, an antifungal drug that is FDA-approved for vaginal yeast infections. There are no published studies comparing FemiClear’s effectiveness to Monistat or other conventional antifungals, and no clinical trials demonstrating that FemiClear reliably clears yeast infections in people.
Bacterial Vaginosis Symptom Relief
The BV product is also a 2-dose vaginal ointment, applied at bedtime on two consecutive nights using a disposable applicator. Its active ingredients are thymol (an antibacterial compound found in thyme) and olive extract. The olive oil in the formula undergoes a patented oxygenation process that, when combined with thymol, is intended to create an ointment with antibacterial properties.
You use half the tube per dose, insert it with the applicator, and remain lying down to prevent leakage. A panty liner is recommended. The product is labeled for adults and children 12 and older.
Genital Herpes Symptom Relief
FemiClear also sells a topical product for managing the symptoms of diagnosed genital herpes outbreaks. This is not an antiviral treatment and does not treat herpes itself. It targets itching, burning, tingling, and pain during outbreaks. The active ingredients are lemongrass, olive extract, and willow bark extract, all listed as homeopathic ingredients.
This positions it differently from prescription antiviral medications, which shorten outbreaks and reduce viral shedding. FemiClear’s herpes product is purely for surface-level comfort during symptoms.
Infection Prevention Product
A separate product in the line, called Infection Protection, is a vaginal cream intended to help prevent BV and yeast infections rather than treat active ones. It also functions as a moisturizer. This is a maintenance product, not something you’d reach for during an active infection.
Regulatory Status: Not FDA-Evaluated
This is an important detail many shoppers miss. FemiClear products are classified as “unapproved homeopathic” products. Their DailyMed listings carry the FDA’s standard disclaimer: “This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.”
Being listed on DailyMed (the FDA’s drug labeling database) does not mean the products are FDA-approved. It means the manufacturer has registered them and submitted labeling information. The ingredients are listed using HPUS designations, which refers to the Homeopathic Pharmacopoeia of the United States, a separate system from conventional pharmaceutical standards.
How FemiClear Compares to Standard Treatments
The core difference comes down to evidence. Monistat’s active ingredient, miconazole, has been through the FDA approval process with clinical trials demonstrating it treats vaginal yeast infections. Miconazole and clotrimazole (another common antifungal) are also considered safe during pregnancy based on clinical data. No comparable studies exist for FemiClear’s yeast infection product.
For genital herpes, prescription antivirals remain the standard of care for reducing outbreak severity and duration. FemiClear’s herpes product offers only symptom relief, similar to applying a soothing topical during an outbreak. It does not compete with antivirals in terms of what it actually does.
FemiClear appeals primarily to people who prefer plant-derived ingredients and want to avoid conventional pharmaceuticals. That’s a personal choice, but it comes with a trade-off: the ingredients in these products have not been clinically proven to treat the conditions they target in the same rigorous way that FDA-approved alternatives have.